Lauxera Capital Partners is an independent, international asset management company focused on growth companies in the healthcare sector. They aim to invest in growth-stage, scientifically de-risked healthcare businesses that have the potential to become durable, market-leading franchises. Their investment philosophy centers around partnering with motivated, world-class managers, providing both capital and expertise to improve the efficiency of the healthcare system, save lives, and reduce costs. With offices in Paris and San Francisco, they are positioned to leverage opportunities in both European and US markets. Lauxera Capital invests across a range of healthcare subsectors, including Medical Devices, Digital Health, Technology-Enabled Services, Life Science Tools, Diagnostics, and Healthcare IT and Data. This diversified approach allows them to capitalize on various trends and innovations within the healthcare landscape. They are led by entrepreneurial company builders and seasoned investors who have extensive experience in shepherding healthcare companies through all stages of growth. The firm’s leadership boasts significant experience, with 50 years of healthcare investing experience and 35 years of leading healthcare scale-ups. This deep industry knowledge and operational expertise enable them to provide valuable guidance and support to their portfolio companies, helping them navigate the complexities of the healthcare market and achieve sustainable growth. Lauxera Capital's investment strategy focuses on creating long-term value by supporting companies that are driving positive change and improving healthcare outcomes.
Preferred startup development maturity for initial funding deployment.
Medical Devices, Digital Health, Technology-Enabled Services, Life Science Tools, Diagnostics, Healthcare IT and Data
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
